— Know what they know.
Not Investment Advice
Also trades as: NVO (NYSE) · $vol 469M · NOVO-B.CO (CPH) · $vol 179M · NOV.DE (XETRA) · $vol 8M · NOVC.DE (XETRA) · $vol 5M · NOVO.TO (TSX) · $vol 0M

NONOF OTC

Novo Nordisk A/S
1W: -4.3% 1M: -21.0% 3M: -24.3% YTD: -29.8% 1Y: -35.0% 3Y: -57.8% 5Y: -22.6%
$37.01
-0.37 (-0.99%)
 
Weekly Expected Move ±4.1%
$34 $36 $37 $39 $40
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 43 · $164.3B mcap · 3.15B float · 0.0023% daily turnover · Short 13% of daily vol

Cash Flow Trends

Operating Cash Flow
$118.8B -1.8% ▼
5Y CAGR: +18.0%
Capital Expenditures
$60.0B -16.9% ▼
5Y CAGR: +22.1%
Free Cash Flow
$58.8B -15.5% ▼
5Y CAGR: +14.5%
Dividends Paid
$51.6B -17.0% ▼
Buybacks
$1.4B +93.1% ▲
Net Change in Cash
$12.6B +899.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$47.8B$55.5B$83.7B$101.0B$102.2B
Depreciation & Amort.$6.0B$7.4B$9.4B$8.5B$14.6B
Stock-Based Comp.$1.0B$1.5B$2.1B$2.3B$0
Change in Working Capital-$8.7B-$5.3B-$12.2B-$12.0B$3.7B
Other Non-Cash Items-$2.5B$6.5B$4.9B-$5.1B-$555M
Operating Cash Flow$55.0B$78.9B$108.9B$121.0B$118.8B
— Investing Activities —
Capital Expenditures-$7.4B-$12.1B-$25.8B-$47.2B-$89.9B
Acquisitions (Net)-$18.3B-$7.1B$0-$82.2B$1.0B
Investment Purchases-$7.1B-$9.7B-$13.3B-$19.8B-$721M
Investment Sales$1.2B$6.6B$8.3B$24.4B$10.6B
Other Investing-$1.0B-$2.6B-$13.1B-$4.1B-$1K
Investing Cash Flow-$31.6B-$24.9B-$43.9B-$128.9B-$79.0B
— Financing Activities —
Net Debt Issuance$15.5B-$2.4B-$1.5B$73.1B$26.2B
Stock Repurchased-$19.4B-$24.1B-$29.9B-$20.2B-$1.4B
Dividends Paid-$21.5B-$25.3B-$31.8B-$44.1B-$51.6B
Other Financing$0$0$0$0-$1.5B
Financing Cash Flow-$25.5B-$51.8B-$63.2B$8.7B-$28.3B
Net Change in Cash-$1.5B$1.9B$1.7B$1.3B$12.6B
Cash End of Period$10.7B$12.7B$14.4B$15.7B$26.4B
Free Cash Flow$47.6B$64.1B$70.0B$69.7B$58.8B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms